Determinants of HIV transmission fitness
Determinants of HIV transmission fitness
批准号:
10025713
负责人:
ERIC J ARTS
金额:
$41.16万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
未结题
起止时间:
2002-09-27 至 2025-04-30
关键词:
AcuteAcute DiseaseAddressAdoptedAffinityApplications GrantsArtsBindingBioinformaticsBloodC-Type LectinsCD4 Lymphocyte CountCD4 Positive T LymphocytesCell LineCellsCervicalCharacteristicsChronicChronic DiseaseCoculture TechniquesCoupledDataDendritic CellsDevelopmentDiseaseDisease ProgressionEffectivenessEvolutionExposure toFemaleFundingGeneticGenetic VariationGlycoproteinsGrantHIVHIV Envelope Protein gp120HIV-1HIV-1 vaccineHeterosexualsHumanImmuneImmune responseIndividualInfectionIntegration Host FactorsLeadLectinLinkMale Genital OrgansMeasuresMethodsModelingMucous MembranePaperPathogenesisPathogenicityPatientsPatternPlasmaPolysaccharidesPopulationPopulation HeterogeneityPrevention strategyPropertyPublicationsPublishingResearchSamplingSexual TransmissionSiteSpecialistSystemSystemic infectionT-LymphocyteTechniquesTestingTh1 CellsTissuesTreatment FailureVaginaVariantViralViral Load resultVirusWomanWorkanalysis pipelinebasechemokinecollegecytokinedesignexperimental studyfitnessglycosylationimprovedin vivomacrophagemalemicrobiomepenispenis foreskinrectalreproductive tractsugartransmission process
中文摘要
假设:HIV包膜糖蛋白(Env)上具有特定糖组成的最小聚糖屏障-
1可能是建立新感染所必需的。在艾滋病毒“选择”一个新的感染,聚糖
Env上的含量/组成可以基于传播的模式和容器(例如直肠,阴茎,
性传播中的包皮、阴道和宫颈组织)以及细胞因子/趋化因子环境,
微生物组了解这些微环境中传播的HIV-1的聚糖组成,
改进基于体液的HIV-1疫苗的设计和有效性。
在过去的15年里,R 01将HIV疾病参数与T细胞中的复制HIV适应性进行了比较,
巨噬细胞、树突细胞共培养物和各种离体非粘膜组织。我们已经证明
患者来源的HIV的竞争性复制适应性是发病机制的替代品,并且在缺乏
与疾病进展密切相关。然而,我们发表的研究表明,
原代HIV-1分离株的“致病性”和“传播性”适应性是完全不同的。使用不同的条件,
暴露于20多种不同的HIV-1衍生物混合物的人阴茎和宫颈内膜(EnC)组织
从急性和慢性疾病中,我们现在对影响艾滋病毒传播的因素有了更清楚的了解。我们
观察到慢性HIV-1在粘膜(阴茎和宫颈)组织中的“捕获”复制,而急性HIV-1在粘膜(阴茎和宫颈)组织中的“捕获”复制,
分离物被携带通过组织(可能通过DC)以感染Th 17或Th 1CD 4 + T细胞。HIV-1,
“逃逸”粘膜组织通常对C型凝集素具有较低的亲和力和较少的N连接糖基化位点。
为了加强这些研究,我们与程序员和生物信息学专家密切合作,
NGS分析管道,以确定多病毒竞争的传播适应性,最近,我们
优化EIS-MS技术以分析gp 120聚糖。
我们提出了四个高度相关的目标来检验我们的假设:
具体目标1。宫颈内(EnC)和血浆样本中HIV-1的体内分析及其决定因素
新的艾滋病毒传播。检查新感染妇女EnC和血液中的Env序列特征,
以及EnC中感染HIV-1但未发生血清转化的妇女。
具体目标2。表征血液中的传播/创始者(TF)HIV变体与
女性和男性生殖道中的HIV-1传播人群:体外研究。测量捕获
组织中的复制与人阴茎、包皮、宫颈和阴道外植体模型中的传播。
具体目标3。测定凝集素结合亲和力并分析gp 120上的糖基化模式,
使用新的gp 120纯化技术和EIS-MS进行高传染性TF HIV-1的Env。
具体目标4。为了修饰TF和EnC病毒上的聚糖,并确定最佳的HIV Env,
使用目标2和3所述的同样方法防止艾滋病毒从男性传播到女性。
英文摘要
Hypothesis: A minimal glycan shield with specific sugar composition on the envelope glycoprotein (Env) of HIV-
1 may be necessary for establishing new infections. In the HIV “selected” for a new infection, glycan
content/composition on Env could differ based on the mode and receptacle of transmission (e.g. rectal, penile,
foreskin, vaginal, and cervical tissue in sexual transmission) as well as the cytokine/chemokine milieu and
microbiome. Understanding glycan composition on the transmitted HIV-1 in these microenvironments would
improve the design and effectiveness of humoral-based HIV-1 vaccine.
For the past 15 years, this R01 has compared HIV disease parameters to replicative HIV fitness in T cells,
macrophages, dendritic cell cocultures, and various ex vivo, non-mucosal tissues. We have shown that
competitive replicative fitness of patient-derived HIV is a surrogate of pathogenesis and in the absence of
treatment, was a strong correlate of disease progression. However, our published work indicates that
“pathogenic” and “transmission” fitness of primary HIV-1 isolates are quite distinct. Using varying conditions with
human explant penile and endocervical (EnC) tissues exposed to over 20 different mixtures of HIV-1 derived
from acute and chronic disease, we now have a clearer picture of factors impacting HIV transmission. We
observed “trapped” replication of chronic HIV-1 in mucosal (penile and cervical) tissue while the acute HIV-1
isolates were carried through the tissue (possibly via DCs) to infect Th17 or Th1 CD4+ T cells. HIV-1 that
“escapes” mucosal tissues typically have lower affinity for C type lectins and fewer N linked glycosylation sites.
To enhance these studies we worked closely with programmers and bioinformatic specialists to develop robust
NGS analysis pipelines to determine transmission fitness from multivirus competitions and more recently, we
optimized EIS-MS techniques to analyze gp120 glycans.
We have proposed four highly inter-related aims to test our hypotheses:
Specific Aim 1. In vivo analyses of HIV-1 in endocervical (EnC) and plasma samples and determinants of
new HIV transmissions. Examine Env sequence features in the EnC and blood of newly infected women as
well as in women with HIV-1 infection in the EnC but who have not seroconverted.
Specific Aim 2. Characterizing the properties of transmitted/founder (TF) HIV variant in blood versus the
transmitted HIV-1 population in the female and male genital tract: Ex vivo study. Measure trapped
replication in the tissue versus transmission in human penile, foreskin, cervical, and vaginal explant model.
Specific Aim 3. To measure lectin binding affinity and to analyze the glycosylation pattern on the gp120
Env of highly transmissible TF HIV-1 using new gp120 purification techniques and EIS-MS.
Specific Aim 4. To modify the glycans on TF and EnC viruses and to determine optimal HIV Env for
male to female HIV transmissions using the same methods described in aims 2 and 3.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ugandan Laboratory Core
-
批准号:7930068
-
项目类别:
-
资助金额:$23.58万
-
财政年份:2010
-
负责人:ERIC J ARTS
-
依托单位:
Consequences of immune escape on viral fitness
-
批准号:7854611
-
项目类别:
-
资助金额:$38.78万
-
财政年份:2010
-
负责人:ERIC J ARTS
-
依托单位:
Ugandan Laboratory
-
批准号:7933416
-
项目类别:
-
资助金额:$11.34万
-
财政年份:2009
-
负责人:ERIC J ARTS
-
依托单位:
New SHIV R5 env's (based on all subtypes) for effective microbicide testing in ma
-
批准号:7536240
-
项目类别:
-
资助金额:$19.83万
-
财政年份:2008
-
负责人:ERIC J ARTS
-
依托单位:
New SHIV R5 env's (based on all subtypes) for effective microbicide testing in ma
-
批准号:7690343
-
项目类别:
-
资助金额:$21.1万
-
财政年份:2008
-
负责人:ERIC J ARTS
-
依托单位:
Impact of HIV-1 Fitness on Disease Progression
-
批准号:7340958
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2007
-
负责人:ERIC J ARTS
-
依托单位:
Impact of HIV-1 Fitness on Disease Progression
-
批准号:7679613
-
项目类别:
-
资助金额:$37.89万
-
财政年份:2007
-
负责人:ERIC J ARTS
-
依托单位:
Impact of HIV-1 Fitness on Disease Progression
-
批准号:8051212
-
项目类别:
-
资助金额:$8.58万
-
财政年份:2007
-
负责人:ERIC J ARTS
-
依托单位:
Impact of HIV-1 Fitness on Disease Progression
-
批准号:7484266
-
项目类别:
-
资助金额:$37.89万
-
财政年份:2007
-
负责人:ERIC J ARTS
-
依托单位:
Impact of HIV-1 Fitness on Disease Progression
-
批准号:7920891
-
项目类别:
-
资助金额:$47.08万
-
财政年份:2007
-
负责人:ERIC J ARTS
-
依托单位:
Impact of HIV-1 Fitness on Disease Progression
-
批准号:8115894
-
项目类别:
-
资助金额:$37.14万
-
财政年份:2007
-
负责人:ERIC J ARTS
-
依托单位:
New Inhibitors of HIV replication
-
批准号:8501111
-
项目类别:
-
资助金额:$41.73万
-
财政年份:2006
-
负责人:ERIC J ARTS
-
依托单位:
CORE--Ugandan Laboratory Core
-
批准号:6802580
-
项目类别:
-
资助金额:$15.04万
-
财政年份:2004
-
负责人:ERIC J ARTS
-
依托单位:
Impact of HIV-1 Fitness on Disease Progression
-
批准号:6496529
-
项目类别:
-
资助金额:$29.65万
-
财政年份:2002
-
负责人:ERIC J ARTS
-
依托单位:
Determinants of HIV transmission fitness
-
批准号:10162476
-
项目类别:
-
资助金额:$41.16万
-
财政年份:2002
-
负责人:ERIC J ARTS
-
依托单位:
Impact of HIV-1 Fitness on Disease Progression
-
批准号:6659933
-
项目类别:
-
资助金额:$29.69万
-
财政年份:2002
-
负责人:ERIC J ARTS
-
依托单位:
Impact of HIV-1 Fitness on Disease Progression
-
批准号:6947276
-
项目类别:
-
资助金额:$29.4万
-
财政年份:2002
-
负责人:ERIC J ARTS
-
依托单位:
Determinants of HIV transmission fitness
-
批准号:10405619
-
项目类别:
-
资助金额:$41.16万
-
财政年份:2002
-
负责人:ERIC J ARTS
-
依托单位:
Impact of HIV-1 Fitness on Disease Progression
-
批准号:6803177
-
项目类别:
-
资助金额:$29.43万
-
财政年份:2002
-
负责人:ERIC J ARTS
-
依托单位:
Impact of HIV-1 fitness on disease progression
-
批准号:8708732
-
项目类别:
-
资助金额:$34.74万
-
财政年份:2002
-
负责人:ERIC J ARTS
-
依托单位:
海外基金